Mr Fangbin Hao | Moyamoya disease | Best Researcher Award

Posted on by Pencis

Mr Fangbin Hao | Moyamoya disease | Best Researcher Award

Attending doctor,Ā Department of Neurosurgery, Chinese PLA General Hospital,Ā China

Dr. Fangbin Hao šŸ‘Øā€āš•ļø is a seasoned and accomplished medical professional specializing in Neurosurgery, with a keen focus on Moyamoya disease. Currently serving as an Attending Doctor in the Department of Neurosurgery at the esteemed Chinese PLA General Hospital, Dr. Hao boasts over 11 years of dedicated contributions to the field.

With a Medical Doctor qualification, he has channeled his expertise towards advancing the understanding and treatment of neurological disorders, placing special emphasis on Moyamoya diseaseā€”a condition affecting the brain’s blood vessels.

Dr. Hao embarked on his career journey in 2019 at the Chinese PLA General Hospital, where he has played a pivotal role in delivering exceptional healthcare and making significant contributions to Neurosurgery research. His unwavering commitment to patient care and research is palpable through his continuous efforts to stay at the forefront of medical advancements.

For any professional inquiries or consultations, feel free to reach out to Dr. Fangbin Hao at šŸ“ž 15313508553 or āœ‰ļø 632072284@qq.com.

Experience

Dr. Fangbin Hao stands out as a highly skilled neurosurgeon with a distinct focus on Moyamoya disease. In his role as an Attending Neurosurgeon, Dr. Hao has made noteworthy contributions to the field, evident in the publication of 18 SCI-indexed papers. His research primarily explores surgical outcomes, risk factors, and diagnostic advancements related to Moyamoya disease, with a special emphasis on the application of high-resolution MRI technology.

Dr. Hao’s commitment to Moyamoya disease research is exemplary, reflecting a dedication to both clinical practice and academic excellence. Through his extensive body of work, he not only enhances our understanding of the disease but also contributes valuable insights that have a lasting impact on the broader field of neurosurgery.

Contribution

Throughout my professional journey, my commitment to research, innovation, and knowledge extension has been central to my contributions. Specializing in Moyamoya disease, šŸ§  my work encompasses 18 SCI-indexed publications, delving into various aspects such as long-term outcomes, collateral circulation, risk factors, and diagnostic advancements using high-resolution MRI. šŸ“Š

Beyond publications, I actively engage in collaborative initiatives nationally and internationally, fostering joint projects and contributing to the organization of research conferences and workshops. šŸŒ My involvement in consultancy and industry-sponsored projects reflects my dedication to translating research into practical applications, aiming to advance clinical practices and patient care. šŸ’”

My multifaceted approach to Moyamoya disease research reflects a commitment to impactful contributions within neurosurgery. As I navigate the realms of research and development, my goal is to bridge academia and practical applications, promoting continuous innovation and meaningful contributions to the scientific community at large. šŸš€

Research Focus

The research conducted by Dr. Hao and his team focuses on the high-resolution magnetic resonance imaging (MRI) vessel wall enhancement in Moyamoya disease, a rare cerebrovascular disorder. šŸ§  Their study explores risk factors and clinical outcomes associated with this enhancement, providing valuable insights into the diagnosis and prognosis of Moyamoya disease.

In parallel investigations, the team delves into proteomic and metabolomic characterizations of Moyamoya disease patient sera, offering a comprehensive understanding of the biochemical aspects of the condition. šŸ§Ŗ Additionally, their work evaluates the diagnostic performance of high-resolution magnetic resonance-vessel wall imaging in differentiating atherosclerosis-associated Moyamoya vasculopathy from Moyamoya disease.

Publications Top notes

  1. High-resolution MRI vessel wall enhancement in moyamoya disease: risk factors and clinical outcomes”
    • Authors: Hao, F., Han, C., Lu, M., … Cai, J., Duan, L.
    • Journal: European Radiology (2024)
    • Link
  2. “Proteomic and metabolomic characterizations of moyamoya disease patient sera”
    • Authors: Guo, Q., Wang, Q.-N., Li, J., … Bao, X., Duan, L.
    • Journal: Brain and Behavior (2023, 13(12), e3328)
    • Link
  3. “The diagnostic performance of high-resolution magnetic resonance-vessel wall imaging in differentiating atherosclerosis-associated moyamoya vasculopathy from moyamoya disease”
    • Authors: Liu, S., Lu, M., Gao, X., … Zhang, H., Cai, J.
    • Journal: European Radiology (2023, 33(10), pp. 6918ā€“6926)
    • Citations: 3
    • Link
  4. “Surgical outcomes following encephaloduroarteriosynangiosis in moyamoya disease associated with hyperhomocysteinemia”
    • Authors: Gao, G., Hao, F.-B., Wang, Q.-N., … Han, C., Duan, L.
    • Journal: Brain and Behavior (2023, 13(8), e3093)
    • Link
  5. “Long-term outcomes of moyamoya disease versus atherosclerosis-associated moyamoya vasculopathy using high-resolution MR vessel wall imaging”
    • Authors: Lu, M., Zhang, H., Liu, S., … Han, C., Cai, J.
    • Journal: Journal of Neurology, Neurosurgery and Psychiatry (2023, 94(7), pp. 567ā€“574)
    • Citations: 3
    • Link
  6. “Association of cognitive function and hypoperfusion in Moyamoya disease patients without stroke”
    • Authors: Shen, X.-X., Zhang, H.-D., Fu, H.-G., … Duan, L., Han, C.
    • Journal: Journal of Cerebral Blood Flow and Metabolism (2023, 43(4), pp. 542ā€“551)
    • Citations: 1
    • Link
  7. “Vessel wall enhancement as a predictor of arterial stenosis progression and poor outcomes in moyamoya disease”
    • Authors: Lu, M., Zhang, H., Liu, D., … Han, C., Cai, J.
    • Journal: European Radiology (2023, 33(4), pp. 2489ā€“2499)
    • Citations: 4
    • Link
  8. “Metabolomic analysis of human plasma sample after exposed to high altitude and return to sea level”
    • Authors: Gao, J., Zhao, M., Cheng, X., … Han, C., Zhu, L.
    • Journal: PLoS ONE (2023, 18(3 March), e0282301)
    • Citations: 1
    • Link

 

 

 

En-Cheng Yang | Neuroanatomy | Best Researcher Award

Posted on by Pencis

Prof Dr. En-Cheng Yang | Neuroanatomy | Best Researcher Award

Professor,Ā Department of Entomology/National Taiwan University,Ā Taiwan

En-Cheng Yang šŸ§ šŸœ, a distinguished male neuroscientist born on May 16, 1965, in Taiwan, Republic of China, has dedicated his career to the intricate field of insect neurobiology. Following his intellectual pursuits, Yang earned his Ph.D. in Neuroscience on September 30, 1994. Currently associated with the Lab of Insect Neurobiology in the Department of Entomology at National Taiwan University, his office is situated at No. 1, Sec. 4, Roosevelt Rd., Taipei. šŸ›ļø Yang’s significant contributions to the scientific community are reflected in his comprehensive understanding of insect neurobiology. His expertise is not limited to academia, as evidenced by his active involvement in research and teaching. Those seeking to connect with this distinguished scientist can reach him via telephone at +886 2 33669640, through fax at +886 2 3365-2092, or electronically at ecyang@ntu.edu.tw. En-Cheng Yang’s commitment to advancing the understanding of insect neurobiology has undoubtedly left an indelible mark on the scientific landscape. šŸŒšŸ”¬

Profile

scopus

springer

Education

En-Cheng Yang’s academic journey is marked by significant milestones and international experiences. šŸŒ In 1988, he earned his B.Sc. in Entomology from the Department of Entomology at National Chung Hsing University in Taichung, Taiwan. šŸŽ“ Continuing his pursuit of knowledge, he embarked on a Master’s course at the Research School of Biological Sciences, Australian National University (ANU), Canberra, Australia, in 1989-90.

En-Cheng’s academic trajectory took a more specialized turn as he transferred to the Ph.D. program at the Centre for Visual Science, Australian National University, from 1990 to 1994. šŸ§  On September 30, 1994, he achieved a significant milestone by obtaining his Ph.D. in Neuroscience, showcasing his dedication to advancing understanding in this intricate field. šŸŽ‰ This international academic exposure undoubtedly enriched his perspective and contributed to his distinguished career in insect neurobiology. šŸœšŸ“š

Experience

En-Cheng Yang’s illustrious career in academia and leadership roles is a testament to his commitment to education and research. šŸŒŸ From 1999 to 2004, he served as an Assistant Professor in the Department of Entomology at National Chung Hsing University. šŸœ During this period, he laid the foundation for his academic journey, contributing significantly to the field.

His dedication and expertise led to subsequent advancements in his career. From 2005 to 2006, he continued as an Associate Professor in the same department at National Chung Hsing University. šŸ“š Yang’s influence expanded when he joined the Department of Entomology at National Taiwan University, where he served as an Associate Professor from 2006 to 2010. šŸ«

Research Focus

En-Cheng Yang’s prolific research portfolio encompasses a diverse array of topics within entomology, neurobiology, and agricultural science. šŸ His groundbreaking work includes investigating the impact of imidacloprid contamination on honeybee olfactory behavior, shedding light on crucial ecological dynamics. šŸÆšŸŒŗ Yang’s contributions extend to the development of web-based agro-ecological monitoring systems, offering innovative solutions for pest control in fruit orchards.

His research spans the realms of insect vision, exploring the diversity of photoreceptors in butterflies and the flash behavior of fireflies in the Alishan area of Taiwan. šŸ¦‹šŸ” Furthermore, Yang’s work delves into the underwater attachment mechanisms of diving beetles and the intricacies of mosquito vector monitoring systems based on optical wingbeat classification.

 

Publications Top Notes

 

  1. Impaired olfactory associative behavior of honeybee workers due to contamination of imidacloprid in the larval stage.
  2. Application of a web-based remote agro-ecological monitoring system for observing spatial distribution and dynamics of Bactrocera dorsalis in fruit orchards.
  3. The distribution, life cycle, and flash behavior of the firefly Pyrocoelia praetexta Olivier (Coleoptera: Lampyridae) in the Alishan area of Taiwan.
  4. Diversity of photoreceptors and spectral opponency in the compound eye of golden birdwing butterfly, Troides aeacus formosanus.
  5. Toxicity and repellence of Taiwanese indigenous djulis, Chenopodium formosaneum, against Aedes albopictus (Diptera: Culicidae) and Forcipomyia taiwana (Diptera: Ceratopogonidae).
  6. A high range accuracy and high sensitivity harmonic radar using pulse pseudorandom code for bee searching.
  7. Signal processing for harmonic pulse radar based on spread spectrum Technology.
  8. Underwater attachment using hairs: the functioning of spatula and sucker setae from male diving beetles.
  9. Firefly ling flashing: Oxygen supply mechanism.
  10. A microwave applicator for uniform irradiation by circularly polarized waves in an anechoic chamber.

 

 

 

 

Veronica Bergottini | Bacterial cellulose biomaterials | Best Researcher Award

Posted on by Pencis

Veronica Bergottini | Bacterial cellulose biomaterials | Best Researcher Award

VerĆ³nica Bergottini, Ph.D., is a distinguished scientist and professor specializing in Biological Sciences. She earned her Ph.D. from the University of NeuchĆ¢tel, Switzerland, in 2015, focusing on the role of native Plant Growth Promoting Rhizobacteria (PGPR) associated with Yerba Mate (Ilex paraguariensis). Her research aimed to assess their potential as bio-inoculants for this vital crop. Earlier, she obtained a B.Sc. in Genetics from the National University of Misiones, Argentina, where her work centered on genetic diversity, molecular taxonomy, and symbiotic efficiency of rhizobia populations.

Currently serving as a Professor-Scientist at the Laboratory of Environmental Biotechnology since April 2018 at Universidad Argentina de la Empresa (UADE), Dr. Bergottini imparts knowledge in General Microbiology, Ecology for Environmental Management, and Biotechnology for Agricultural Management. Her commitment to advancing scientific understanding and education is commendable. šŸŒæšŸ”¬

profile

springer

Scopus

Education šŸ“ššŸŒ±

Dr. VerĆ³nica Bergottini embarked on her academic journey with a Ph.D. in Biological Sciences from the University of NeuchĆ¢tel, Switzerland (Sep. 2013 – May 2015). Her dissertation delved into the intricate task of evaluating the role of native Plant Growth Promoting Rhizobacteria (PGPR) associated with Yerba Mate (Ilex paraguariensis) as bio-inoculants for this crucial crop. Prior to her doctoral studies, she earned a B.Sc. in Genetics from the National University of Misiones, Argentina, focusing on the genetic diversity, molecular taxonomy, and symbiotic efficiency of rhizobia populations that nodulate Lotus tenuis.

Her academic journey began at Hindenburg Schule in Eldorado, Misiones, for Primary and Secondary School education. Dr. Bergottini’s research contributions and dedication to scientific exploration underscore her commitment to advancing our understanding of plant-microbe interactions. šŸŒšŸ”¬

Experience

Dr. VerĆ³nica Bergottini is a distinguished Professor-Scientist at the Laboratory of Environmental Biotechnology, Universidad Argentina de la Empresa (UADE) since April 2018. Her impactful courses include General Microbiology for Biotech and Food Engineers (2018-2022), Ecology for Environmental Management (2018-2022), and Biotechnology for Agricultural Management (2018-2023).

Adding to her academic repertoire, Dr. Bergottini assumed the role of Professor in Biomaterials and Design at Universidad Torcuato Di Tella, Argentina, starting April 2022. Simultaneously, she has been instrumental in the production of Kombucha and Research + Development in Biomaterials at Karu Fermentos since March 2018.

Her entrepreneurial spirit shone as she served as the Laboratory Responsible at Kwell levaduras from February 2017 to January 2018. Additionally, she contributed as a Doctoral Assistant in Microbiology at the University of Neuchatel, Switzerland, from Sep. 2014 to May 2015. Dr. Bergottini’s diverse roles reflect her dedication to fostering knowledge and innovation. šŸŒ±šŸ”¬

Achievements & Recognitions šŸ†šŸŒ

Dr. VerĆ³nica Bergottini stands as an Ambassador of the PROESUS Program in 2020 and held the esteemed position of National Minister of Environment in 2019, showcasing her dedication to environmental causes.

Her entrepreneurial spirit earned her the prestigious Innovar Award in the Entrepreneur category in 2019. Dr. Bergottini was a Finalist of the WISE Awards (Women in STEM) at IAE in the same year, emphasizing her contributions to the fields of science, technology, engineering, and mathematics.

Acknowledged as a Semifinalist of NAVES NACIONAL ā€“IAE 2019 and a Finalist of the Talent Brother Awards in Sustainable Fashion Edition EAMODA 2017, she has consistently demonstrated her commitment to innovation and sustainability.

Dr. Bergottini’s academic prowess is evident through her receipt of an academic prize for her PhD thesis at the Faculty of Sciences, University of NeuchĆ¢tel in 2015. Additionally, she was a recipient of the Swiss Government Excellence Scholarships for Foreign Scholars during her research internship from 2011-2013. Earlier, she received scholarships from the ComitĆ© Ejecutivo de Desarrollo e InnovaciĆ³n (CEDIT) and the Agencia Nacional de PromociĆ³n CientĆ­fica y TecnolĆ³gica for her research endeavors. šŸŒŸšŸ”¬

 

Publications Top NotesĀ 

Bacterial cellulose aerogel enriched in nanofibers obtained from Kombucha SCOBY byproduct.

  • Materials Today Communications, 2023

Trichoderma ā€“based inoculants: An eco-friendly option to enhance Eruca sativa and Lactuca sativa productivity and sanity.

  • Innova UNTREF, 2020

Exploring the diversity of the root-associated microbiome of Ilex paraguariensis St. Hil (Yerba Mate).

  • Applied Soil Ecology, 2017

Bio-inoculation of yerba mate seedlings (Ilex paraguariensis St. Hill.) with native plant growth-promoting rhizobacteria: A sustainable alternative to improve crop yield.

  • Biology and Fertility of Soils, 2015

Genome Sequence of Kosakonia radicincitans Strain YD4, a Plant Growth-Promoting Rhizobacteria isolated from yerba mate (Ilex paraguariensis St. Hill.).

  • Genome Announcement, 2015

Comparative symbiotic performance of native rhizobia of the Flooding Pampa and strains currently used for inoculating Lotus tenuis in this region.

  • Antonie van Leeuwenhoek, 2011
  • Contributed equally with Sannazzaro AL

 

 

Herbert Meltzer | Schizophrenia | Best Scholar Award

Posted on by Pencis

Herbert Meltzer | Schizophrenia | Best Scholar Award

šŸ‘Øā€āš•ļø Prof. Herbert Y. Meltzer, M.D., is a distinguished psychiatrist currently affiliated with Northwestern University’s Feinberg School of Medicine in Chicago, Illinois. His office is located at 303 East Chicago Avenue, Ward Bldg 7-101, and 680 N. Lakeshore Prof. Suite 1520, Chicago, IL 60611.

šŸŽ“ Prof. Meltzer’s academic journey began at Cornell University, where he earned his B.A. with honors in 1958. He continued his education with an M.A. at Harvard University in 1959 and obtained his M.D. from Yale University in 1963, accompanied by a Certificate in Community Psychiatry. Committed to advancing mental health, he participated in the Associate Faculties Program in Community Psychiatry at the Washington School of Psychiatry from 1966 to 1968.

šŸ† Prof. Meltzer’s extensive contributions to psychiatry and academic excellence underscore his impact on the field. His current association with Northwestern University reflects a continued dedication to advancing psychiatric research and education. šŸŒšŸ§ 

Profile

scopus

pubmed

x-mol

researchgate

Education

šŸŽ“ Prof. Herbert Y. Meltzer’s academic journey is marked by excellence. He earned his B.A. from Cornell University in 1958, showcasing early academic prowess. Subsequently, he pursued an M.A. at Harvard University in 1959 and achieved an M.D. from Yale University in 1963. His commitment to community psychiatry is evident through his Certificate in Community Psychiatry and participation in the Associate Faculties Program in Community Psychiatry at the Washington School of Psychiatry from 1966 to 1968. Prof. Meltzer’s educational trajectory reflects a dedication to advancing mental health knowledge and practice. šŸ«šŸ“ššŸ‘Øā€āš•ļø

Honors and Awards

šŸŽ“ Dr. Herbert Y. Meltzer, an esteemed figure in the field of chemistry and neuropsychopharmacology, graduated with distinction and honors in chemistry from Cornell University. His academic journey is adorned with prestigious accolades, including the Phi Beta Kappa honor, New York State Regent’s and Cornell University Scholarships, the Dean’s Scholarship at Cornell, the Telluride Associate Scholarship, and the George Chapman Caldwell Prize in Chemistry.

šŸ”¬ Dr. Meltzer continued his academic pursuits with a General Electric Fellowship in Chemistry at Harvard and a Dean’s Scholarship at Yale University School of Medicine. Notably, his impactful career includes a Research Scientist Development Award from the National Institute of Mental Health (NIMH) and an Efron Award from the American College of Neuropsychopharmacology. His excellence in academia is further highlighted by the Arthur P. Noyes Award in Schizophrenia from the Commonwealth of Pennsylvania. Dr. Meltzer’s achievements have left an indelible mark on the scientific community, earning him a place in Who’s Who in America. šŸ†šŸ§Ŗ

MembershipsĀ 

Dr. Herbert Y. Meltzer holds prestigious memberships in various esteemed organizations, showcasing his dedication to advancing the field of neuropsychopharmacology and psychiatry. As a distinguished member of the American College of Neuropsychopharmacology, American Psychiatric Association, and the American Association for the Advancement of Science, he contributes to cutting-edge research and practices. His involvement in the Collegium Internationale Neuropsychopharmacologicum, New York Academy of Sciences, Society for Neuroscience, Society of Biological Psychiatry, and the International Society for CNS Clinical Trials and Methodology reflects his global engagement in neuroscientific endeavors. šŸ§ 

These memberships underscore Dr. Meltzer’s commitment to staying at the forefront of scientific developments and collaborating with experts worldwide, reinforcing his impact on advancing our understanding of neuropsychopharmacology and mental health. šŸŒ

Publication top notes

Polygenic risk scores analyses of psychiatric and metabolic traits with antipsychotic-induced weight gain in schizophrenia: an exploratory study

  • Pharmacogenomics Journal, 23(5):119ā€“126, 2023.
  • Link
  • Citations: 1

Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia

  • Journal of Clinical Psychopharmacology, 43(3):211ā€“219, 2023.
  • Link
  • Citations: 3

Neuroendocrine Studies in Psychiatric Disorders: The Role of Serotonin

  • The Role of Serotonin in Psychiatric Disorders, 2023, pp. 57ā€“90.
  • Link
  • Citations: 7

Role of advanced glycation end products in the longitudinal association between muscular strength and psychotic symptoms among adolescents

Schizophrenia risk loci from xMHC region were associated with antipsychotic response in chronic schizophrenic patients with persistent positive symptom

  • Translational Psychiatry, 12(1):92, 2022.
  • Link
  • Citations: 3

Awareness of illness moderates self-assessment of psychotic symptoms

  • Australian and New Zealand Journal of Psychiatry, 56(10):1287ā€“1294, 2022.
  • Link
  • Citations: 1

Repeated administration of rapastinel produces exceptionally prolonged rescue of memory deficits in phencyclidine-treated mice

  • Behavioural Brain Research, 432:113964, 2022.
  • Link
  • Citations: 1

 

Lakshmi Rajagopal | Schizophrenia | Best Researcher Award

Posted on by Pencis

Dr. Lakshmi Rajagopal | Schizophrenia | Best Researcher Award

Dr. Lakshmi Rajagopal, an accomplished Indian researcher in Neuropsychopharmacology, has earned recognition with the Best Researcher Award for her groundbreaking work in schizophrenia. Holding a Ph.D. from the University of Bradford, UK, her dissertation focused on Neonatal Phencyclidine (PCP) induced deficits in rats, contributing to schizophrenia research. With expertise in behavioral testing and immunohistochemistry, Dr. Rajagopal has made significant contributions during her tenure at Northwestern University, Feinberg School of Medicine, Chicago. Currently a Research Assistant Professor, she has excelled in her roles as a Postdoctoral Research Fellow and Research Associate. A recipient of the O1 visa, she is in the process of obtaining an EB1 visa. Dr. Rajagopal’s career showcases a commitment to advancing our understanding of neuropsychiatric disorders. šŸ†šŸ§ 

Education

Dr. Lakshmi Rajagopal, an esteemed Neuropsychopharmacologist, earned her Ph.D. from the University of Bradford, UK, from 2008 to 2011. Her dissertation, “Neonatal Phencyclidine (PCP) induced deficits in rats,” showcased her expertise in behavioral testing and immunohistochemistry, under the guidance of Prof. Joanna Neill and Dr. Michael Harte at Manchester University. She furthered her academic journey with a Masters in Environmental Protection from Delhi University (1995-1997) and a B.Sc. in Zoology from Womenā€™s Christian College, Chennai (1992-1995). Dr. Rajagopal, dedicated to scientific inquiry, has seamlessly blended her passion for neuroscience and environmental protection. Her academic odyssey is a testament to her commitment to understanding the intricacies of the brain and the environment. šŸ§ šŸ”¬šŸŒæ

Experience

Dr. Lakshmi Rajagopal, a dynamic researcher, has played pivotal roles at Northwestern University’s Feinberg School of Medicine since 2012. As a Postdoctoral Research Fellow (2012-2019) and Research Associate (2019-2022), she excelled in behavioral neuroscience, establishing and managing the Behavioral Core of the laboratory. Dr. Rajagopal, currently a Research Assistant Professor, has expertise in diverse behavioral paradigms and techniques such as Western Blot and immunohistochemistry. Notably, she initiated and produced constitutive and conditioned 5-HT7 knock-out mice, contributing to four ongoing first-author research manuscripts. As the DEA liaison, she manages controlled substances, while overseeing IACUC protocols, grant applications, and supervising interns and candidates. In her prior role as Quality Manager at LG Medical Transcription, she efficiently led a team of 500+ editors/transcriptionists from 1999 to 2003. šŸ§ šŸ”¬šŸ‘©ā€šŸ”¬

Awards and Honors

Dr. Lakshmi Rajagopal is a distinguished researcher recognized with numerous honors. Acknowledged by the United States Army, Navy, and Air Force, she received a certificate for outstanding mentorship of a summer intern at the Junior Science & Humanities Symposium in 2016. Her commitment to excellence garnered the prestigious “Service Excellence Award” from Northwestern University’s Feinberg School of Medicine in 2017. Dr. Rajagopal’s international acclaim includes Travel Awards from the British Association of Pharmacology for poster presentations in 2009 and 2010, as well as full Travel Awards for abstract/poster presentations at CINP in Florence (2010) and ECNP in France (2008). Notably, she was nominated and featured in Marquis Whoā€™s Who as one of the top researchers in America in 2017. šŸ†šŸŒšŸ”¬

Areas of Expertise

Dr. Lakshmi Rajagopal is a distinguished expert in Neuropsychopharmacology, Neuropharmacology, and Behavioral Pharmacology. Her multifaceted expertise encompasses cognition, psychosis, Major Depressive Disorder, Alzheimerā€™s Disease, and the experimental design of animal behavior tests. Specializing in the pharmacology of preclinical models, she excels in statistical analyses, molecular and neuropathological investigations, and the study of neuroinflammation. Dr. Rajagopal’s comprehensive understanding spans the intricate interplay between pharmacological interventions and neural mechanisms, contributing significantly to the fields of neuroscience and psychiatry. šŸ§ šŸ’ŠšŸ­

Publications Top Notes

“The dopamine D1 receptor positive allosteric modulator, DETQ, improves cognition and social interaction in aged mice and enhances cortical and hippocampal acetylcholine efflux.”

“NU-1223, a simplified analog of alstonine, with 5-HT2cR agonist-like activity, rescues memory deficit and positive and negative symptoms in subchronic phencyclidine mouse model of schizophrenia.”

“Repeated Administration of Rapastinel Produces Exceptionally Prolonged Rescue of Memory Deficits in Phencyclidine-Treated Mice.”

“Pimavanserin augments the efficacy of atypical antipsychotic drugs in a mouse model of treatment-refractory negative symptoms of schizophrenia.”

“Depolarizing GABAA current in the prefrontal cortex is linked with cognitive impairment in a mouse model relevant for schizophrenia.”

“Systematic analysis of brain lactate and pH levels in 65 animal models related to neuropsychiatric conditions.”

“The D1 Positive Allosteric Modulator, DETQ, Improves Cognition in Aged Mice and Enhances Cortical and Hippocampal Acetylcholine Efflux.”

“Effects of NBI-98782, a selective vesicular monoamine transporter 2 (VMAT2) inhibitor, on neurotransmitter efflux and phencyclidine-induced locomotor activity: Relevance to tardive dyskinesia and antipsychotic action.”

“The allosteric dopamine D1 receptor potentiator, DETQ, ameliorates subchronic phencyclidine-induced object recognition memory deficits and enhances cortical acetylcholine efflux in male humanized D1 receptor knock-in mice.”

 

Yanru Jiang | Representational Learning | Best Researcher Award

Posted on by Pencis

Ms. Yanru Jiang | Representational Learning | Best Researcher Award

Yanru Jiang is a trailblazing researcher in Representational Learning, currently pursuing a Ph.D. in Communication at the University of California, Los Angeles (UCLA). šŸŽ“ Under the guidance of Dr. Jungseock Joo and Dr. Rick Dale, she has excelled in her academic journey, also earning an M.S. in Statistics. Yanru has garnered prestigious accolades, including being a Meta PhD Fellowship Finalist and securing the UCLA Graduate Council Diversity Fellowship. šŸ† Her dedication extends to research mentorship, as evidenced by her participation in the UCLA Graduate Student Research Mentorship Program. Yanru’s passion for education and innovative contributions make her a standout figure in the academic realm.

Profile

Scopus

Education

Yanru Jiang is on an academic journey marked by excellence, pursuing a Ph.D. in Communication at the University of California, Los Angeles (UCLA) šŸŽ“. Guided by Dr. Jungseock Joo and Dr. Rick Dale, she delves into the intricate realm of communication. Complementing this, Yanru earned an M.S. in Statistics, showcasing her multidisciplinary prowess. šŸ“Š Prior to UCLA, she excelled at the University of Southern California, achieving a Master of Communication Management and a B.S. in Business Administration with a concentration in Cinematic Arts. šŸŽ¬ Yanru’s diverse educational background reflects her commitment to interdisciplinary learning and positions her as a standout scholar.

Experience

Yanru Jiang seamlessly blends academic expertise with practical experience, teaching Communication Methods and Film Persuasion at UCLA šŸ“š. As an integral part of UCLA’s Computational Media Lab under PI Jungseock Joo and the Co-Mind Lab led by PI Rick Dale, she explores cutting-edge research in communication and computational media šŸ§ šŸ’». Yanru has contributed significantly to the field, previously engaging in research at the Artificial Intelligence and Emerging Media Lab at Boston University and diverse projects spanning education, political science, and AI. šŸŒ Her dynamic professional background includes roles as an AI Engineer, NLP Research Intern, and Financial Analyst at renowned organizations like Beyond Limits, Testin, and Cybernaut Zfounder Ventures. šŸš€

Honors & Awards

Yanru Jiang stands out as a rising scholar, achieving recognition through prestigious awards and fellowships. šŸŒŸ As a Meta PhD Fellowship Finalist (110 of 3200), she exemplifies academic excellence and innovation. Yanru’s commitment to research is underscored by her UCLA ISH Research Innovation Fund Finalist ($100,000) and the UCLA Graduate Council Diversity Fellowship ($66,000). šŸ† Her involvement in impactful programs, such as the UCLA Graduate Student Research Mentorship Program and the USC Center for International Studies Research Assistantship, reflects her dedication to academic exploration. Yanru’s impressive array of grants and awards, including those from APSA and ICA, solidify her position as a distinguished researcher. šŸŽ“

Publication

  1. Automated Nonverbal Cue Detection in Political-Debate Videos: An Optimized RNN-LSTM Approach
    • Author: Y. Jiang
    • Year: 2024
    • šŸ“‘šŸ¤–
  2. Transformability, generalizability, but limited diffusibility: Comparing global vs. task-specific language representations in deep neural networks
    • Authors: Y. Jiang, R. Dale, H. Lu
    • Year: 2024
    • šŸ“‘šŸ§ 
  3. The impact of political ideology, knowledge and participation on electoral conspiracy endorsement
    • Author: Y. Jiang
    • Year: 2023
    • šŸ“‘šŸ—³ļø
  4. Validating a Mixed-Method Approach for Multilingual News Framing Analysis: A case study of COVID-19
    • Authors: G. AkƧakır, Y. Jiang, J. Luo, S. Noh
    • Year: 2023
    • šŸ“‘šŸ“°
  5. An Unsupervised Approach to Discover Media Frames
    • Authors: S. Lai, Y. Jiang, L. Guo, P. Ishwar, D.T. Wijaya
    • Year: 2022
    • šŸ“‘šŸ”
  6. David vs. Goliath: transnational grassroots outreach and empirical evidence from the #HongKongProtests Twitter network
    • Authors: C.S.Y. Shea, Y. Jiang, W.L.Y. Leung
    • Year: 2022
    • šŸ“‘šŸŒ
  7. Using k-Means Clustering to Classify Protest Songs Based on Conceptual and Descriptive Audio Features
    • Authors: Y. Jiang, X. Jin
    • Year: 2022
    • šŸ“‘šŸŽ¶

 

 

 

Mei Huang | Schizophrenia | Best Researcher Award

Posted on by Pencis

Mei Huang | Schizophrenia | Best Researcher Award

Dr. Mei Huang šŸŒŸ, an accomplished researcher in schizophrenia and neuropharmacology, has dedicated her career to unraveling the complexities of mental health. With a Ph.D. from Shenyang Pharmaceutical University, China, she conducted pioneering postdoctoral research at Vanderbilt University, USA. Serving as a Research Assistant Professor at Northwestern University, Chicago, she’s earned accolades such as the NARSAD Young Investigator Award and CINP Young Investigator Award. šŸ† Dr. Huang’s extensive contributions extend to editorial roles and collaborative grants, investigating novel therapies for cognitive function and neurotransmitter regulation. Her passion for advancing psychiatric understanding is evident in her diverse and impactful research endeavors. šŸ‘©ā€šŸ”¬šŸ§ šŸ”

Profile:

Scopus

Education:

Dr. Mei Huang’s academic journey reflects a profound commitment to understanding the intricacies of medicine. šŸ“š From 1994 to 1998, she pursued her Bachelor’s in Pharmacy, specializing in Chinese Traditional Medicine at the esteemed School of Chinese Traditional Medicine, Shenyang Pharmaceutical University, China. šŸ›ļø Building on this foundation, she earned her Ph.D. in Neuropharmacology from the Department of Pharmacology, School of Pharmacy, Shenyang Pharmaceutical University, from September 1998 to August 2002. šŸŽ“ Her academic pursuits showcase a seamless blend of traditional and modern medicine, setting the stage for a career dedicated to advancing neuropharmacological research. šŸ‘©ā€šŸ”¬šŸŒæšŸ§ 

Experience:

Dr. Mei Huang’s academic odyssey seamlessly transitioned from her postdoctoral roles to impactful academic appointments in prestigious institutions. šŸŒ Beginning at Shenyang Pharmaceutical University, China, she thrived as a Postdoctoral Research Fellow and Teaching Assistant from August 2002 to July 2003. šŸ« Her journey continued across continents as she pursued postdoctoral research at Vanderbilt University, USA, from August 2003 to July 2008. šŸ‡ŗšŸ‡ø Subsequently, she made significant contributions as a Research Assistant Professor at Vanderbilt University (2008ā€“2012) and later at Northwestern University, Chicago, where she presently serves. šŸŽ“ Dr. Huang’s diverse roles underscore her dedication to advancing knowledge in pharmacology and psychiatry. šŸ‘©ā€šŸ”¬šŸŒŸšŸ§ 

Award & Honors:

Dr. Mei Huang’s exceptional contributions in schizophrenia research earned her prestigious accolades. šŸ† In 2005, she received the NARSAD Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression, USA, recognizing her groundbreaking work. šŸŒ The following year, in 2006, she was honored with the CINP Young Investigator Award, further solidifying her impact on neuro-psychopharmacology. šŸ§  Her dedication continued, with another NARSAD Young Investigator Award in 2007, emphasizing her sustained excellence in advancing understanding and treatment of schizophrenia and related mental health disorders. šŸŒŸšŸ‘©ā€šŸ”¬šŸŽ‰

Publications:

  1. “NU-1223, a simplified analog of alstonine, with 5-HT2cR agonist-like activity, rescues memory deficit and positive and negative symptoms in subchronic phencyclidine mouse model of schizophrenia”
    • Authors: Rajagopal, L., Mahjour, S., Huang, M., Scheidt, K., Meltzer, H.Y.
    • Year: 2023
    • Citation: Behavioral Brain Research, 454, 114614
    • šŸ§ šŸ­šŸŒŸ
  2. “Repeated administration of rapastinel produces exceptionally prolonged rescue of memory deficits in phencyclidine-treated mice”
    • Authors: Rajagopal, L., Huang, M., He, W., Banerjee, P., Meltzer, H.Y.
    • Year: 2022
    • Citation: Behavioral Brain Research, 432, 113964
    • šŸ”„šŸ­šŸŒ
  3. “An autophagy-related protein Becn2 regulates cocaine reward behaviors in the dopaminergic system”
    • Authors: Kim, Y.-J., Kong, Q., Yamamoto, S., Xu, M., He, C.
    • Year: 2021
    • Citation: Science Advances, 7(8), eabc8310
    • šŸƒšŸ§ šŸ‘ƒ
  4. “Effects of NBI-98782, a selective vesicular monoamine transporter 2 (VMAT2) inhibitor, on neurotransmitter efflux and phencyclidine-induced locomotor activity: Relevance to tardive dyskinesia and antipsychotic action”
    • Authors: Huang, M., He, W., Rajagopal, L., Grigoriadis, D.E., Meltzer, H.Y.
    • Year: 2020
    • Citation: Pharmacology Biochemistry and Behavior, 190, 172872
    • āš™ļøšŸš¶ā€ā™‚ļøšŸ”¬
  5. “The allosteric dopamine D1 receptor potentiator, DETQ, ameliorates subchronic phencyclidine-induced object recognition memory deficits and enhances cortical acetylcholine efflux in male humanized D1 receptor knock-in mice”
    • Authors: Meltzer, H.Y., Rajagopal, L., Matrisciano, F., Svensson, K.A., Huang, M.
    • Year: 2019
    • Citation: Behavioral Brain Research, 361, 139ā€“150
    • šŸŽÆšŸ­šŸŒˆ
  6. “Activation of dopamine receptor 2 prompts transcriptomic and metabolic plasticity in glioblastoma”
    • Authors: Caragher, S.P., Shireman, J.M., Huang, M., Tryba, A.K., Ahmed, A.U.
    • Year: 2019
    • Citation: Journal of Neuroscience, 39(11), 1982ā€“1993
    • šŸ§¬šŸ§ šŸ’”
  7. “The role of dopamine D3 receptor partial agonism in cariprazine-induced neurotransmitter efflux in rat hippocampus and nucleus accumbens”
    • Authors: Huang, M., He, W., Kiss, B., Adham, N., Meltzer, H.Y.
    • Year: 2019
    • Citation: Journal of Pharmacology and Experimental Therapeutics, 371(2), 517ā€“525
    • šŸ”„šŸ€šŸ”
  8. “TPA-023 attenuates subchronic phencyclidine-induced declarative and reversal learning deficits via GABA A receptor agonist mechanism: possible therapeutic target for cognitive deficit in schizophrenia”
    • Authors: Rajagopal, L., Huang, M., Michael, E., Kwon, S., Meltzer, H.Y.
    • Year: 2018
    • Citation: Neuropsychopharmacology, 43(12), 2468ā€“2477
    • šŸŽ“šŸ­šŸ”¬
  9. “5-HT1A partial agonism and 5-HT7 antagonism restore episodic memory in subchronic phencyclidine-treated mice: role of brain glutamate, dopamine, acetylcholine, and GABA”
    • Authors: Huang, M., Kwon, S., Rajagopal, L., He, W., Meltzer, H.Y.
    • Year: 2018
    • Citation: Psychopharmacology, 235(10), 2795ā€“2808
    • šŸŒˆšŸ­šŸ“š
  10. “Dissecting the Functional Consequences of De Novo DNA Methylation Dynamics in Human Motor Neuron Differentiation and Physiology”
    • Authors: Ziller, M.J., Ortega, J.A., Quinlan, K.A., Meissner, A., Kiskinis, E.
    • Year: 2018
    • Citation: Cell Stem Cell, 22(4), 559ā€“574.e9
    • šŸ”¬šŸ§¬šŸš¶ā€ā™‚ļø

 

Madhumita Ghosh | Retinal Degeneration and Diabetic retinopathy | Women Researcher Award

Posted on by Pencis

Madhumita Ghosh | Retinal Degeneration and Diabetic retinopathy | Women Researcher Award

In 2023, Dr. Madhumita Ghosh was honored with the prestigious Woman Researcher Award, a testament to her exceptional contributions in the study of Retinal Degeneration and Diabetic Retinopathy. Her journey began with a Ph.D. from Jadavpur University in 2001, where she demonstrated a profound commitment to academic excellence. Subsequently, she enriched her expertise as a Research Associate at AIIMS, New Delhi, and expanded her horizons through a Visiting Post Doctoral Fellowship at the National Eye Institute, NIH, Bethesda, USA, from 2002 to 2004. Dr. Ghosh further advanced her research at the National Brain Research Center, New Delhi, from 2004 to 2008, before joining the Amity Institute of Biotechnology in 2008 and rising to the position of Associate Professor in 2019. Her dual roles in educationā€”contributing significantly to Animal Biotechnology and Immunology classesā€”reflect her dedication to both scholarly pursuits and mentorship. The Woman Researcher Award underscores her impactful achievements and underscores her role as a beacon of inspiration for aspiring researchers in her field globally.

Profile:

Scopus

Orcid

Google Scholar

Education:

Dr. Madhumita Ghosh šŸŒ embarked on her academic journey with a Ph.D. from Jadavpur University, Kolkata (1995-2001), marking the genesis of her profound expertise. Following this, she contributed as a Research Associate at AIIMS, New Delhi (2001-2002), and broadened her horizons with a Visiting Post Doctoral Fellowship at the National Eye Institute, NIH, Bethesda, USA (2002-2004). Returning to India, she continued her postdoctoral endeavors at the National Brain Research Center, New Delhi (2004-2008). šŸ§  These diverse experiences laid the foundation for her illustrious career, positioning her as a seasoned researcher with a global perspective in the realm of neuroscience. šŸŒšŸ‘©ā€šŸ”¬

Experience:

From 2008 to 2011, Dr. Madhumita Ghosh assumed the role of Senior Lecturer at the Amity Institute of Biotechnology, Amity University, Noida, India, contributing significantly to academic growth. šŸŽ“ Transitioning seamlessly, she served as an Assistant Professor from 2011 to 2019, leaving an indelible mark on the institution’s biotechnology landscape. šŸŒ± Her dedication and prowess have been further acknowledged since 2019, as she currently holds the position of Associate Professor at the Amity Institute of Biotechnology. šŸš€ Dr. Ghosh’s enduring commitment to education underscores her influential role in shaping the next generation of biotechnologists. šŸ‘©ā€šŸ«šŸ”¬

Research Activity:

Dr. Madhumita P. Ghosh šŸŒŸ, an accomplished Associate Professor at Amity Institute of Biotechnology since 2019, boasts a stellar research portfolio. šŸ§Ŗ Her impactful work includes a Department of Biotechnology grant in 2016, exploring lithium’s antiapoptotic properties against retinal ganglion cell degeneration. šŸ¤– She led a Department of Science and Technology project (2017-2020) on dopamine treatment in diabetic retinopathy, unraveling insights into angiogenesis. šŸ©øšŸ‘ Currently, she mentors a Ph.D. student in a project studying VEGF’s role using Trolox and CoQ10 against NMDA-induced toxicity. Her groundbreaking contributions to retinal research showcase her dedication and leadership in advancing eye health. šŸ‘©ā€šŸ”¬šŸ”āœØ

Publications:

“Trolox aids coenzyme Q10 in neuroprotection against NMDA induced damage via upregulation of VEGF in rat model of glutamate excitotoxicity”

Authors: Upreti, S., Nag, T.C., Ghosh, M.P.

Year: 2024

Citation: Experimental Eye Research, 238, 109740

šŸ§ šŸ‘āœØ

“Insulin-like growth factor-1 works synergistically with dopamine to attenuate diabetic retinopathy by downregulating vascular endothelial growth factor”

Authors: Upreti, S., Sen, S., Nag, T.C., Ghosh, M.P.

Year: 2022

Citation: Biomedicine and Pharmacotherapy, 149, 112868

šŸ”„šŸŒ±šŸ‘

“Trolox assisted inhibition of glutamate excitotoxicity-mediated degeneration in retina”

Authors: Upreti, S., Ghosh, M.P.

Year: 2022

Citation: Contemporary Medical Biotechnology Research for Human Health, pp. 79ā€“90

šŸ§ŖšŸ‘šŸš«

“Rapid Electrochemical Quantification for In Vitro Release Trait of Ophthalmic Drug Loaded within Mucoadhesive Metal Organic Framework (MOF)”

Authors: Chansi, Upreti, Punya, Ghosh, M.P., Basu, T.

Year: 2021

Citation: ChemistrySelect, 6(12), pp. 3006ā€“3012

āš”šŸ’§šŸ‘

“Mutations associated with retinopathies alter mitogen-activated protein kinase-induced phosphorylation of neural retina leucine-zipper”

Authors: Swain, P., Kumar, S., Patel, D., Ghosh, M., Swaroop, A.

Year: 2007

Citation: Molecular Vision, 13, pp. 1114ā€“1120

šŸ§¬šŸ”„šŸ‘

“Lack of fiber cell induction stops normal growth of rat lenses in organ culture”

Author: Ghosh, M.P., Zigler Jr., J.S.

Year: 2005

Citation: Molecular Vision, 11, pp. 901ā€“908

šŸ§ŖšŸ‘šŸ”’

“A spontaneous mutation affects programmed cell death during development of the rat eye”

Authors: Sinha, D., Hose, S., Zhang, C., Ghosh, M.P., Lo, W.-K., Zigler Jr., J.S.

Year: 2005

Citation: Experimental Eye Research, 80(3), pp. 323ā€“335

šŸŒ€šŸ’”šŸ‘

 

Paola Valentino | Biomarkers | Best Researcher Award

Posted on by Pencis

Dr. Paola Valentino | Biomarkers | Best Researcher Award

šŸ”¬ Dr. Paola Valentino, a trailblazing leader in biomarkers at the University of Turin, spearheads groundbreaking initiatives in translational research. šŸŒ As the driving force behind the establishment of the Department’s biobank, she expertly manages cryogenic facilities, informed consent procedures, and sample/data documentation. Her extensive research fellowship at the Neuroscience Institute focused on Multiple Sclerosis and NMOSD, delving into biomarkers like Neurofilament Light Chain and anti-aquaporin 4 antibodies. šŸ§Ŗ Dr. Valentino excels in quality management, shaping the CRESM Biobank’s protocols and legal documents while actively contributing to national and international biobanking initiatives. šŸŒ Her rich background, spanning from gene expression analysis to board certification in clinical and analytical biochemistry, showcases her multidisciplinary prowess. šŸŽ“ Fluent in Italian, with proficiency in English and French, Dr. Valentino is a dynamic force in the intersection of science, ethics, and biobanking standards. šŸŒŸ

Profile:

Scopus

Orcid

Education:

šŸ‘©ā€šŸŽ“ Dr. Paola Valentino, a Turin native, embarked on her academic journey with a Bachelor’s degree in Medical Biotechnology (L1) from the University of Turin in 2003. šŸŽ“ Her commitment to excellence continued as she earned a Master’s degree in Medical Biotechnology (9/S) on 23/07/2003, solidifying her expertise in the field. šŸ§Ŗ Driven by a passion for analytical biochemistry, she achieved Board Certification in Clinical and Analytical Biochemistry from the University of Turin on 27/07/2005. šŸ† These educational milestones laid the foundation for her remarkable career as a leader in biomarker research and biobanking. šŸŒŸ

Experience:

šŸŒŸ Dr. Paola Valentino is a dynamic force in the world of biomarkers, currently serving as Technical Administrative Personnel at the University of Turin since 03/07/2023. šŸ›ļø Her impactful role involves establishing the biobank for the Department of Clinical and Biological Sciences, overseeing cryogenic facilities, documentation, informed consent, and managing samples and data. šŸ§Ŗ Concurrently, she engages in cutting-edge translational research activities, focusing on biomarkers.

šŸ”¬ Prior to her current position, Dr. Valentino held a significant role at the Neuroscience Institute Cavalieri Ottolenghi (NICO)/University Hospital San Luigi Gonzaga from 18/09/2006 to 30/06/2023. During this tenure, her research spanned multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD). Notably, she pioneered studies on Neurofilament Light Chain as a biomarker, validated methods for anti-aquaporin 4 antibodies, and explored the diagnostic potential of anti-potassium channel KIR4.1 antibodies.

šŸŒ Dr. Valentino’s impact extends to quality management in the CRESM biobank since 08/04/2021, where she defines sample collection protocols, updates databases, implements biobank software, and ensures compliance with ethical and legal standards, including GDPR. šŸŒ Her diverse expertise also includes participating in international biobanking working groups, contributing to standards like UNI ISO 20387, and collaborating on gene expression analysis with the Italian Foundation for Multiple Sclerosis. šŸ¤ Dr. Valentino’s multifaceted contributions solidify her as a key figure in the intersection of research, biobanking, and quality management.

Publication:

  • Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder
    • Author: Carta, S., Dinoto, A., Capobianco, M., … Marignier, R., Mariotto, S.
    • Year: 2024
    • Journal: Neurology(R) Neuroimmunology & Neuroinflammation, 11(1), pp. e200188
  • Ocrelizumab Extended Interval Dosing in Primary Progressive Multiple Sclerosis: An Italian Experience
    • Authors: ZanghƬ, A., Ferraro, D., Callari, G., … Avolio, C., Dā€™amico, E.
    • Year: 2024
    • Journal: Current Neuropharmacology, 22(2), pp. 339ā€“345
  • Cerebrospinal fluid neurofilament light chains predict early disease activity in Multiple Sclerosis
    • Authors: Toscano, S., Oteri, V., Chisari, C.G., … Zappia, M., Patti, F.
    • Year: 2023
    • Journal: Multiple Sclerosis and Related Disorders, 80, 105131
  • Correction to: Daytime sleepiness and sleep quality in Charcotā€“Marieā€“Tooth disease (Journal of Neurology)
    • Authors: Bellofatto, M., Gentile, L., Bertini, A., … Iabichella, G., Barone, S.
    • Year: 2023
    • Journal: Journal of Neurology, 270(11), pp. 5569ā€“5570
  • Daytime sleepiness and sleep quality in Charcotā€“Marieā€“Tooth disease
    • Authors: Bellofatto, M., Gentile, L., Bertini, A., … Iabichella, G., Barone, S.
    • Year: 2023
    • Journal: Journal of Neurology, 270(11), pp. 5561ā€“5568
  • Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register
    • Authors: Mosconi, P., Guerra, T., Paletta, P., … Zaffaroni, M., Zarbo, R.
    • Year: 2023
    • Journal: Neurological Sciences, 44(11), pp. 4001ā€“4011
  • Serum Neurofilaments are a reliable biomarker to early detect PML in Multiple Sclerosis patients
    • Authors: Valentino, P., Malucchi, S., Bava, C.I., … Di Sapio, A., Bertolotto, A.
    • Year: 2023
    • Journal: Multiple Sclerosis and Related Disorders, 77, 104893
  • Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey
    • Authors: Altieri, M., Capuano, R., Bisecco, A., … Tedeschi, G., Gallo, A.
    • Year: 2023
    • Journal: Multiple Sclerosis and Related Disorders, 77, 104870
  • The one-and-a-half syndrome: a distinctive clinical finding in a patient with multiple sclerosis
    • Authors: Fratto, E., Barone, S., Tinelli, E., … Gambardella, A., Valentino, P.
    • Year: 2023
    • Journal: Neurological Sciences, 44(9), pp. 3331ā€“3333
  • Clinical spectrum and frequency of Charcotā€“Marieā€“Tooth disease in Italy: Data from the National CMT Registry
    • Authors: Pisciotta, C., Bertini, A., Tramacere, I., … Vita, G., Pareyson, D.
    • Year: 2023
    • Journal: European Journal of Neurology, 30(8), pp. 2461ā€“2470

 

 

Saad Javeed | Cervical spine disease | Best Researcher Award

Posted on by Pencis

Dr.Saad Javeed | Cervical spine disease | Best Researcher AwardĀ 

šŸ‘Øā€āš•ļø Saad Javeed is a dynamic medical professional currently serving as a Resident in General Surgery at Washington University School of Medicine. šŸŽ“ With a background in Neurosurgery and a Master’s in Clinical Investigation, he is a dedicated researcher, earning the Best Researcher Award for his work on cervical spine diseases. šŸŒ Hailing from Sharif Medical and Dental College in Lahore, Pakistan, Saad’s journey includes impactful roles as a Postdoctoral Research Fellow and Research Trainee, contributing significantly to nerve transfer surgeries, spinal cord injury outcomes, and bone growth induction. šŸ„ Committed to clinical excellence, his leadership shines through various roles, fostering literary and scientific discourse(Cervical spine disease).

Profile:

Scopus

Education:

šŸ‘Øā€šŸŽ“ Saad Javeed embarked on his medical journey at Sharif Medical and Dental College in Lahore, Pakistan, graduating with distinction with a Bachelor of Medicine, Bachelor of Surgery (M.B.B.S) from 2012 to 2017. šŸ„ During this time, he immersed himself in core clinical rotations at Sharif Medical City and Ittefaq Trust Hospital, Lahore, while also dedicating his time as a volunteer in the Emergency department.

šŸŒ Expanding his horizons, Saad pursued a Master of Science in Clinical Investigation (MSCI) at Washington University School of Medicine in St. Louis, MO, from 2021 to 2023. šŸ§Ŗ His research focus during this period involved a cutting-edge project on biomarker discovery in Chronic Entrapment Neuropathy. šŸ¤ Under the guidance of primary mentor Dr. Wilson Ray and secondary mentor Dr. David Brogan, Saad showcased his commitment to advancing medical knowledge and improving patient outcomes. šŸŒŸ

Research:

šŸŒ Saad Javeed, a dedicated Postdoctoral Research Fellow at Ray Lab, Neurosurgery, Washington University School of Medicine, explores the intricate realm of spinal health. Under the mentorship of Dr. Wilson Z. Ray, M.D., his clinical endeavors delve into nerve transfers for cervical spinal cord injuries, optimizing treatment algorithms for tetraplegia, and pioneering research in spinal cord injury outcomes and predictive modeling. šŸ¤– Additionally, Saad integrates mobile health technology into spinal surgery outcomes. In the realm of basic science, he investigates electrical stimulation for bone growth post-fracture and spinal fusion, objective biomarkers in chronic entrapment neuropathy, and techniques to enhance nerve regeneration after peripheral nerve injury. šŸ§ šŸ”¬

Clinical experience:

šŸ‘Øā€āš•ļø Saad Javeed’s medical journey unfolds as a Preliminary Resident in General Surgery (PGY1) at Washington University School of Medicine since 2023, showcasing his commitment to surgical excellence. šŸŒŸ His summer of 2022 was marked by a Sub-Internship in Neurosurgery at the same institution, honing his skills in this specialized field. šŸ§  Prior experiences include a Neurosurgery Clinical Observership at the University of Miami Miller School of Medicine in 2019 and a Spring 2019 Clinical Observership in Neurology at the University of South Florida School of Medicine. šŸ„ In 2018-2019, Saad engaged in a Clinical Elective, serving as a Medical Scribe at Dominion Cardiovascular Specialists in Richmond, VA. šŸ’‰

Honors and Awards:

šŸ† Saad Javeed’s accolades form a stellar constellation, reflecting his prowess in medicine and research. In 2016, he earned the Student Medical Volunteer Award at Sharif Medical City and assumed the role of Student President of the Literary Society at Sharif Medical and Dental College. šŸ“· His artistic talents were recognized with the Best Abstract Portrait in the Intercollegiate Medical College Photography Competition. Fast forward to 2021 and beyond, Saad’s contributions reached new heights, including a Journal Cover Illustration Award from JNS Spine and a string of honors for abstract presentations and posters at prestigious conferences, solidifying his status as a trailblazer in peripheral nerve surgery. šŸŒŸšŸ§ 

Publications:

šŸ“š Publication: “Revision Anterior Cervical Discectomy and Fusion and Revision Cervical Arthroplasty Are Associated with Similar Outcomes: Real-World Analysis from a National Quality Registry”

šŸ‘„ Authors:

  • Tsai, S.H.L.
  • Alvi, M.A. šŸ§ 
  • Tazyeen, S.
  • Bydon, M.
  • Elder, B.D.

šŸ“… Year: 2021

šŸ”— Journal: Turkish Neurosurgery, 31(6), pp. 952ā€“961

 

šŸ“š Publication: “Prevalence and Trends in Management of Idiopathic Normal Pressure Hydrocephalus in the United States: Insights from the National Inpatient Sample”

šŸ‘„ Authors:

  • Alvi, M.A. šŸ§ 
  • Brown, D.
  • Yolcu, Y.
  • Cogswell, P.M.
  • Elder, B.D.

šŸ“… Year: 2021

šŸ”— Journal: World Neurosurgery, 145, pp. e38ā€“e52